Status:
UNKNOWN
Auricular Transcutaneous Electrical Nerve Stimulation Treatment of Autism
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
In this study, investigators will examine the treatment effects of transcutaneous electrical nerve stimulation with different stimulation frequencies on individuals with autism.
Detailed Description
In this study, investigators will examine the treatment effect of transcutaneous electrical nerve stimulation at auricular area with vagus nerve distribution on high-functioning individuals with autis...
Eligibility Criteria
Inclusion
- Autism diagnosed based on DSM-V classification criteria
- 18-60 year old high functioning adult autism patients (e.g. Asperger's, IQ equal or greater than 80)
- Subjects who do not show aggressive behaviors based on neuro/psychiatric evaluations as determined by a licensed study physician.
Exclusion
- A history of chronic serious infection, any current infection, any type of cancer or autoimmune disease or other severe diseases;
- Subjects taking any medications that confound the study results
Key Trial Info
Start Date :
October 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 28 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03827941
Start Date
October 1 2022
End Date
January 28 2024
Last Update
September 9 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.